New bowel cancer treatment a step closer

New tests to help doctors know whether bowel cancer treatments are likely to work have come a step closer to NHS funding in England, according to webmd. For some people with advanced or metastatic bowel cancer, a genetic mutation called KRAS oncogene means they won’t respond well to some treatments. Knowing this means they can avoid treatments which won’t help but may have caused unpleasant side effects. The draft guidance has been welcomed by Bowel Cancer UK. Bowel cancer Bowel cancer, also called colorectal cancer, is the third most common cancer in the UK with around 40,000 people diagnosed with